Microlife Microlife
  • Prodotti Domiciliari
    • BP A6 Advanced Easy_red_logo Pressione arteriosa
    • trasp_NON CONTACT Febbre
    • trasp_NEB NANO_half-acc_PRINT_LOcopy1 Terapia respiratoria
    • trasp_WS 80n_half Controllo del peso
    • Software_downloads_allg Software
  • Prodotti Professionali
    • WatchBP Office ABI_front_cuff WatchBP Office
    • WatchBP O3 Ambulatory AFIB_front_cuff WatchBP 03
    • WatchBP Home A_front_cuff WatchBP Home
    • Cuff-Ankle Bracciali e Accessori
    • Software Software
  • Tecnologie
  • Magazine
  • Azienda
    • aboutus Chi siamo
    • Events Eventi e News
    • contact Contatti
    • History Storia
ITALIA
Italiano
Europe
  • EUROPE - English
  • CZECHIA - Čeština
  • DANMARK - Dansk
  • DEUTSCHLAND - Deutsch
  • ESPAÑA - Español
  • FRANCE - Français
  • HRVATSKA - Hrvatski
  • ITALIA - Italiano
  • LATVIJA - Latviešu
  • LIETUVA - Lietuvių
  • MAGYARORSZÁG - Magyar
  • NEDERLAND - Nederlands
  • ÖSTERREICH - Deutsch
  • POLSKA - Polski
  • PORTUGAL - Português
  • SCHWEIZ - Deutsch
  • SLOVENSKO - Slovenčina
  • SLOVENIJA - Slovenščina
  • SUOMI - Suomi
  • SCHWEIZ - Français
  • UK - English
  • ΕΛΛΆΔΑ - Ελληνικά
  • БЪЛГАРИЯ - Български
  • СРБИЈА - Српски
  • УКРАЇНА - Українська
  • TÜRKIYE - Türkçe
  • РОССИЯ - Русский
  • БЕЛАРУСЬ - Русский
Asia
  • ASIA PACIFIC - English
  • VIỆT NAM - Tiếng Việt
  • ประเทศไทย - ไทย
  • 中国 - 中文
  • 台灣 - 中文
Middle East and North Africa
  • MENA - Arabic عربى
USA, Latin America
  • US - English
  • AMÉRICA DEL SUR - Español
  • COLOMBIA - Español
  • MÉXICO - Español
Menu
Headerpictures WatchBP Validations AFIB Flow

Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations

Home > Prodotti Professionali
Share

Willem J. Verberk, Stefano Omboni, Anastasios Kollias, George S. Stergiou, 2016

Clinical Study of Microlife WatchBP AFIB

Abstract

Several guidelines recommend opportunistic screening for atrial fibrillation (AF) in subjects aged ≥65 years using pulse palpation during routine blood pressure (BP) measurement. However, this method has limited diagnostic accuracy. A specific algorithm for AF detection during automated BP measurement was developed and implemented in a novel oscillometric device (MicrolifeWatchBP Home-A). In 2013, theUKNational Institute for Health and Care Excellence (NICE) recommended this device for AF screening during routine office BP measurement in primary care in subjects ≥65 years. A review and meta-analysis of the evidence on the diagnostic accuracy of this algorithm were performed. Six studies (n=2332) investigated the accuracy of AF detection using the Microlife BP monitor and estimated a pooled sensitivity at 0.98 (95% CI 0.95, 1.00) and specificity 0.92 (0.88, 0.96). Analysis of 4 studies (n= 1126) showed more readings to improve specificity (from 0.86 to 0.91) and sensitivity (from 0.97 to 0.99). Taking 3 sequential readings with at least 2 detecting AF gave the highest diagnostic accuracy. A single study (n=139) of paroxysmal AF screening with home BP monitoring (3316 days) showed sensitivity 99% and specificity 93%. Another study (n = 46) of AF screening with 24 h ambulatory BP monitoring showed that AF detected in N15% of all readings has high probability of AF diagnosis requiring confirmation by 24 h electrocardiography. AF detection with routine automated BP measurement is a reliable screening tool in the elderly, which requires confirmation by electrocardiography. Paroxysmal AF might also be detected by routine automated home or ambulatory BP monitoring.

 

Download Abstract as PDF-file:

http://www.microlife.com/media/1475/download/Verberk_2016-CS,%20AFIB.pdf?v=1

WatchBP Office AFIB_front_cuff

WatchBP Office AFIB

View product
WatchBP Home A_half_cuff

WatchBP Home A

View Product
Microlife
  • Contatti
  • Sede Legale
  • Privacy & Cookie Policy
  • Termini di utilizzo
  • Sviluppatori
Login
Copyright © 2025 - Microlife Corporation. All rights reserved.